Skip to main content
. Author manuscript; available in PMC: 2019 Apr 2.
Published in final edited form as: Rev Recent Clin Trials. 2015;10(3):238–245. doi: 10.2174/157488711003150928130654

Table 2.

Baseline characteristics of PLCO participants who responded to the Supplemental Questionnaire (SQX), non-responders, and those were deceased or otherwise ineligible to complete the SQX

SQX Responders N=104,478 SQX Non-Responders N=30,370 Deceased/Ineligible* N=20,049
N (%)
Gender
Male 49,602 (47.5) 14,878 (49.0) 12,202 (60.9)
Female 54,876 (52.5) 15,492 (51.0) 7,847 (39.1)
Age at Randomization (years)
55–59 37,385 (35.8) 10,403 (34.3) 3,899 (19.4)
60–64 33,226 (31.8) 8,850 (29.1) 5,475 (27.3)
65–69 22,549 (21.6) 6,695 (22.0) 5,686 (28.4)
70+ 11,318 (10.8) 4,422 (14.6) 4,989 (24.9)
Race
White 93,536 (89.5) 23,248 (76.6) 15,795 (78.8)
Black 3,225 (3.1) 3,165 (10.4) 1,318 (6.6)
Other/Missing 7,717 (7.4) 3,957 (13.0) 2,936 (14.6)
BMI (kg/m2)
18.5–25 34,588 (33.1) 8,888 (29.3) 6,087 (30.4)
25–30 43,193 (41.3) 11,862 (39.1) 7,429 (37.1)
>30 23,283 (22.3) 7,744 (25.5) 4,592 (22.9)
Unknown/Missing 3,414 (3.3) 1,876 (6.2) 1,941 (9.7)
Smoking Status
Never smoker 49,584 (47.5) 13,214 (43.5) 6,474 (32.3)
Former Smoker 44,035 (42.2) 11,916 (39.2) 8,666 (43.2)
Current Smoker 8,777 (8.4) 3,893 (12.8) 3,385 (16.9)
Unknown/Missing 2,082 (2.0) 1,347 (4.4) 1,524 (7.6)
*

Ineligibles include those who withdrew from follow-up or were lost to follow-up prior to administration of the SQX